New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
CAMP4 Therapeutics Corporation (CAMP) vs Eikon Therapeutics, Inc. (EIKN)
- CAMP4 Therapeutics Corporation CAMP 3.79 −5.25%
- Eikon Therapeutics, Inc. EIKN 4.74 −0.42%
CAMP4 Therapeutics Corporation and Eikon Therapeutics, Inc. are both Biotechnology companies. CAMP4 Therapeutics Corporation and Eikon Therapeutics, Inc. are of similar size ($257.9M and $251.0M). Across the 8 metrics below, Eikon Therapeutics, Inc. leads on 5 and CAMP4 Therapeutics Corporation on 3.
Valuation
Profitability
| Metric | CAMP | EIKN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 70.18% |
| Operating margin | (1,001.05%) | — | 0.00% |
| Net margin | (2,276.33%) | — | 0.00% |
| Free cash flow margin | — | — | 0.00% |
| Return on equity | (146.12%) | 359.35% | (51.58%) |
| Return on assets | (109.89%) | (56.31%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack